Pediatric Academic Societies (PAS) 2023 Meeting

Complex chronic conditions (CCCs) in children are associated with numerous brief hospitalizations, with a high rate of readmissions, according to a study presented at PAS 2023.

Use of a breathing retraining biofeedback device has been shown to ameliorate panic symptoms in children, particularly among those aged 13 to 17 years, reports a study presented at PAS 2023.

A 50,000-IU loading dose of oral vitamin D plus 8,000 IU daily is effective and safe for increasing serum 25(OH)D levels to ≥40 ng/mL in children and adolescents with asthma who were overweight or obese, as opposed to the standard of care (SoC) dose of 600 IU daily, according to findings from the VDORA1* trial.

In the post hoc analysis of data from the phase III LIBERTY ASTHMA VOYAGE study, the monoclonal antibody dupilumab reduced exacerbations and improved lung function in children aged between 6 and 11 years with moderate-to-severe asthma and baseline blood eosinophil count of ≥500 cells/μL.

Children born to mothers who were exposed to polluted air while pregnant are at increased risk of childhood attention-deficit hyperactivity disorder (ADHD), according to a study presented at PAS 2023.

Treatment with phentermine, topiramate, or their combination appears to help children with severe, complicated obesity shed weight, according to real-world data.